source
- Experts discuss combination and sequencing approaches for radiopharmaceuticals in advanced prostate cancerDr. Pedro Barata and Dr. Johann De Bono review the current questions surrounding how best to combine and sequence radiopharmaceutical therapies for patients with metastatic castration‑resistant pro…
- U.S. overdose deaths drop 14% in 2025, marking third consecutive yearly declinePreliminary CDC data show about 70,000 overdose deaths in 2025, roughly 14% fewer than in 2024 and similar to 2019 levels before the pandemic. The decline was observed across major drug categories…